FDA Inspection 1167830 — Lannett Company, Inc.

Lannett Company, Inc. — FEI 2510865

The FDA completed an inspection of Lannett Company, Inc. on March 25, 2022 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 25, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Philadelphia, PA (United States)